These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 2273661)

  • 41. Highly elevated serum CA 125 levels in a patient with cardiac failure.
    Hopman EH; Helmerhorst TJ; Bonfrer JM; Ten Bokkel Huinink WW
    Eur J Obstet Gynecol Reprod Biol; 1993 Jan; 48(1):71-3. PubMed ID: 8449265
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Children with bronchial dilatations erroneously placed on sanatorium treatment].
    CHEVALIER V
    Acta Paediatr Belg; 1952; 6(3):111-6. PubMed ID: 14932998
    [No Abstract]   [Full Text] [Related]  

  • 43. A 56-year-old man with a normal chest radiograph, elevated CA 19-9, and multiple hepatic lesions.
    Anwer M; Diaz-Fuentes G; Niazi M; Venkatram S
    J Bronchology Interv Pulmonol; 2011 Apr; 18(2):191-5. PubMed ID: 23169096
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Accelerated phase of idiopathic pulmonary fibrosis].
    Altube Urrengoetxea L; Salinas Solano C; Aburto Barrenetxea M; Moraza Cortés FJ; Ballaz Quincoces A; Capelastegui Sainz A
    Arch Bronconeumol; 2007 Sep; 43(9):516-8. PubMed ID: 17919419
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Serum CA 125 levels in patients with non-malignant liver diseases without ascites.
    Collazos J; Genolla J; Allende MT; Ruibal A
    Clin Investig; 1993 Mar; 71(3):239. PubMed ID: 8481627
    [No Abstract]   [Full Text] [Related]  

  • 46. CA 72.4 serum levels in 298 patients with non-malignant diseases.
    Sagredo E; Soriano A; Pombo L; Roiz MC; Allende MT; Ruibal A
    Int J Biol Markers; 1989; 4(2):125. PubMed ID: 2768890
    [No Abstract]   [Full Text] [Related]  

  • 47. [An original cause of elevation of serum CA 125].
    Meicler P; Darai E
    Presse Med; 1994 Feb; 23(7):345. PubMed ID: 8208696
    [No Abstract]   [Full Text] [Related]  

  • 48. [CA 19.9 and pulmonary fibrosis].
    Medranda Gómez MA; Paricio Núñez P; Tovar Martínez A; Ferrer Marín F; Gónzalez Martínez P; García Puche MJ
    Rev Esp Enferm Dig; 2005 Nov; 97(11):843-4. PubMed ID: 16438631
    [No Abstract]   [Full Text] [Related]  

  • 49. [Incidence, course and prognosis of active pulmonary tuberculosis in asbestosis].
    BOHLIG H; JACOB G; MULLER H
    Z Tuberk Erkr Thoraxorg; 1963 Apr; 120():42-9. PubMed ID: 13968463
    [No Abstract]   [Full Text] [Related]  

  • 50. Traction bronchiectasis: is it as benign as we think?
    Bekki A; Beauperthuy T; Martínez-García MÁ
    J Bras Pneumol; 2022 Jul; 48(4):e20220220. PubMed ID: 35894416
    [No Abstract]   [Full Text] [Related]  

  • 51. The carbohydrate composition of pulmonary secretions.
    POTTER JL; MATTHEWS LW; LEMM J; SPECTOR S
    J Pediatr; 1962 Aug; 61():297-8. PubMed ID: 14488293
    [No Abstract]   [Full Text] [Related]  

  • 52. LETTER TO THE EDITOR: Is the Determination of CA-125 Serum Levels Useful for the Diagnosis of Pulmonary Tuberculosis?
    Collazos J
    Open Respir Med J; 2010 Mar; 4():15-6. PubMed ID: 20448811
    [No Abstract]   [Full Text] [Related]  

  • 53. Bronchial Asthma and Pulmonary Tuberculosis.
    Foggie WE
    Edinb Med J; 1933 Mar; 40(3):113-116. PubMed ID: 29646724
    [No Abstract]   [Full Text] [Related]  

  • 54. On Pulmonary Diseases.
    Sutton T
    Lond Med Phys J; 1816 Mar; 35(205):182-190. PubMed ID: 30493878
    [No Abstract]   [Full Text] [Related]  

  • 55. Molecular biomarkers in interstitial lung diseases.
    De Lauretis A; Renzoni EA
    Mol Diagn Ther; 2014 Oct; 18(5):505-22. PubMed ID: 24935523
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The utility of tumor markers CA 125, CA 15-3, and CA 19-9 in assessing the response to therapy in pulmonary and pleural tuberculosis.
    Tascı C; Ozkaya S; Ozkara B; Tozkoparan E; Ozkan M; Karadurmus N; Serdar M; Balkan A; Bilgic H
    Onco Targets Ther; 2012; 5():385-90. PubMed ID: 23209372
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Serum biomarkers in interstitial lung diseases.
    Tzouvelekis A; Kouliatsis G; Anevlavis S; Bouros D
    Respir Res; 2005 Jul; 6(1):78. PubMed ID: 16042760
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Serum sialyl Lewis X-i antigen in lung adenocarcinoma and idiopathic pulmonary fibrosis.
    Satoh H; Ishikawa H; Yamashita YT; Ohtsuka M; Sekizawa K
    Thorax; 2002 Mar; 57(3):263-6. PubMed ID: 11867833
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [CA 19-9 in patients with benign pulmonary diseases].
    Takayama S; Kataoka N; Usui Y; Inase N; Natori Y; Nakayama M; Miura H; Kimula Y
    Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Oct; 28(10):1326-31. PubMed ID: 2273661
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Significance of serum surfactant protein-D (SP-D) level in patients with pulmonary tuberculosis].
    Kondo A; Oketani N; Maruyama M; Taguchi Y; Yamaguchi Y; Miyao H; Mashima I; Oono M; Wada K; Tsuchiya T; Takahashi H; Abe S
    Kekkaku; 1998 Oct; 73(10):585-90. PubMed ID: 9844346
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.